Study guide

Contact-lens optics, materials and tear lenses

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Contact-lens optics, materials and tear lenses

Key Takeaways Explain This Topic AI

Contact lenses alter vertex distance, retinal image effects and near prismatic effects compared with spectacles.

Oxygen transmissibility depends on material permeability and lens thickness rather than water content alone.

A steeper rigid-lens base curve creates a plus tear lens, requiring an appropriate minus power adjustment.

Last updated: October 2026

Note

Contact lens practice in ophthalmology combines precise geometric optics, corneal physiological mechanics, and infectious disease vigilance. Examination candidates must be prepared to calculate tear lens vergence, assess sodium fluorescein clearance patterns, and differentiate sterile infiltrates from fulminant microbial keratitis.

Optical Comparison: Spectacles versus Contact Lenses

Placing a corrective lens directly onto the pre-corneal tear film alters retinal image size, ocular field of view, prismatic aberrations, and vergence demands compared to spectacle wear.

Optical Parameter Spectacle Lenses Contact Lenses Clinical & Physiological Consequence

Vertex Distance ( d d d ) 10 − 14 mm 10 - 14\text{ mm} 10 − 14 mm ( 0.010 − 0.014 m 0.010 - 0.014\text{ m} 0.010 − 0.014 m ) 0 mm 0\text{ mm} 0 mm ( d = 0 d = 0 d = 0 ) Minus contact lenses require less minus power ; plus contact lenses require more plus power than spectacles.

Retinal Image Size ( S M SM SM ) High minus creates minification ( S M < 1 SM \lt 1 SM < 1 ); high plus creates magnification ( S M > 1 SM \gt 1 SM > 1 ). Retinal image size approximates unity ( S M ≈ 1.0 SM \approx 1.0 SM ≈ 1.0 ) because shape factor and vertex distance are minimized. High myopes perceive larger, sharper images in contact lenses; high hyperopes lose spectacle magnification.

Visual Field & Scotomas Restricted by frame aperture; high plus lenses induce a ring scotoma (jack-in-the-box phenomenon). Full, natural peripheral field of view without frame borders or ring scotoma. Essential visual rehabilitation advantage in aphakia, high myopia, and sports vision.

Prismatic Deviations Prismatic effects occur in eccentric gaze according to Prentice's rule ( P = c × F P = c \times F P = c × F ). Minimal prismatic deviation because contact lenses move with the visual axis of the eye. Eliminates reading-induced induced prism and improves binocular motor stability.

Accommodative Demand at Near Myopes accommodate less in spectacles than contact lenses; hyperopes accommodate more . Myopes accommodate more in contact lenses; hyperopes accommodate less . A borderline presbyopic myope switching to contact lenses becomes prematurely symptomatic at near.

Convergence Demand at Near Minus spectacles provide base-in prism when converging, reducing convergence effort. Contact lenses eliminate base-in prism, requiring greater physical convergence. Myopic contact lens wearers exhibit higher phoria strain and convergence fatigue at near.

Knapp's Rule & Anisometropia

Knapp's rule states that if a spectacle lens is placed at the anterior focal point of the eye (approximately 15.7 mm 15.7\text{ mm} 15.7 mm anterior to the cornea), the retinal image size in axial ametropia remains identical to that of an emmetropic eye. Conversely, in refractive ametropia (e.g., unilateral aphakia or keratoconus), contact lenses minimize aniseikonia and are the optical treatment of choice. In modern clinical practice, contact lenses are favored for both axial and refractive anisometropia because cortical sensory fusion, peripheral visual field continuity, and prismatic comfort outweigh theoretical spectacle magnification predictions.

Contact Lens Materials & Oxygen Transmissibility

The corneal epithelium relies on atmospheric oxygen dissolved in the pre-corneal tear film ( P O 2 ≈ 155 mmHg P_{O2} \approx 155\text{ mmHg} P O 2 ​ ≈ 155 mmHg open eye; P O 2 ≈ 55 mmHg P_{O2} \approx 55\text{ mmHg} P O 2 ​ ≈ 55 mmHg closed eye palpebral conjunctiva).

Material Categories

Rigid Gas-Permeable (RGP): Fluoro-silicone acrylate polymers. Deliver high intrinsic oxygen permeability ( D k = 30 − 150 + Barrers Dk = 30 - 150+\text{ Barrers} D k = 30 − 150 + Barrers ) through fluorine-silicone chains. Rigidity helps maintain the designed anterior optical surface, masking corneal astigmatism and ectasia.

Conventional hydrogels transport oxygen largely through their water component. Dk depends on formulation and water content; a single formula or 35–40 upper bound does not describe every material.

Silicone Hydrogels (SiHy): Crosslinked siloxane phases combined with hydrophilic hydrogel phases. Oxygen diffuses directly through silicone pathways independent of water content, delivering high oxygen permeability ( D k = 100 − 175 + Barrers Dk = 100 - 175+\text{ Barrers} D k = 100 − 175 + Barrers ). Higher modulus of elasticity makes lenses stiffer, occasionally provoking mechanical complications.

The Holden-Mertz & Harvitt-Bonnano Criteria

Oxygen transmissibility ( D k / t Dk/t D k / t ) measures oxygen flux through a lens of center thickness t t t (in cm):

Oxygen transmissibility is permeability divided by lens thickness (Dk/t). Compare values using the same units and measurement conditions; central and local thickness, wear schedule and tear exchange affect physiology.

Holden-Mertz Daily Wear Threshold (1984): Minimum D k / t ≥ 24 × 10 − 9 Dk/t \ge 24 \times 10^{-9} D k / t ≥ 24 × 1 0 − 9 to avoid day-time corneal stromal oedema.

Holden-Mertz Extended Wear Threshold (1984): Minimum D k / t ≥ 87 × 10 − 9 Dk/t \ge 87 \times 10^{-9} D k / t ≥ 87 × 1 0 − 9 to limit nocturnal closed-eye stromal oedema to physiological levels ( < 4 % \lt 4\% < 4% , equivalent to overnight sleep without lenses).

Harvitt-Bonnano Closed-Eye Threshold (1999): Updated human mathematical model requiring D k / t ≥ 125 × 10 − 9 Dk/t \ge 125 \times 10^{-9} D k / t ≥ 125 × 1 0 − 9 to eliminate nocturnal hypoxia across the entire full-thickness cornea.

Tear Lens (Lacrimal Lens) Optics & RGP Fitting Principles

When a rigid gas-permeable lens rests on the cornea, the fluid reservoir between the posterior lens surface and the anterior corneal surface forms a tear lens (lacrimal lens).

Astigmatic Neutralization Principle

The refractive index of human tears ( n tear = 1.336 n_{\text{tear}} = 1.336 n tear ​ = 1.336 ) is virtually identical to that of the corneal stroma ( n cornea = 1.376 n_{\text{cornea}} = 1.376 n cornea ​ = 1.376 ), differing sharply from air ( n = 1.000 n = 1.000 n = 1.000 ). The tear lens neutralizes approximately 90 % 90\% 90% of anterior corneal toricity , transforming the irregular or toroid cornea into a spherical optical interface. Residual astigmatism may reflect internal optics, incomplete masking, lens flexure or fitting effects, and should be measured by over-refraction.

The SAM-FAP Rule

The base curve (BC) of an RGP lens defines the anterior surface curvature of the tear lens, while the cornea's flat keratometry reading ( K flat K_{\text{flat}} K flat ​ ) defines its posterior surface curvature:

Fitting On-K ( B C = K flat BC = K_{\text{flat}} BC = K flat ​ ): The anterior and posterior surfaces of the tear lens are parallel. Tear lens power is 0.00 D 0.00\text{ D} 0.00 D (plano) .

Fitting Steeper than K ( B C > K flat BC \gt K_{\text{flat}} BC > K flat ​ in dioptric power, or shorter radius): The tear lens forms a positive meniscus, adding convergent plus power to the optical system. To compensate: SAM (Steeper Add Minus) .

Fitting Flatter than K ( B C < K flat BC \lt K_{\text{flat}} BC < K flat ​ in dioptric power, or longer radius): The tear lens forms a negative meniscus, adding divergent minus power. To compensate: FAP (Flatter Add Plus) . Power Adjustment = 0.25 D lens power compensation per 0.05 mm change in base curve ( ≈ 0.25 D ) \text{Power Adjustment} = 0.25\text{ D lens power compensation per } 0.05\text{ mm change in base curve } (\approx 0.25\text{ D}) Power Adjustment = 0.25 D lens power compensation per 0.05 mm change in base curve ( ≈ 0.25 D )

Worked Tear Lens Calculation:

Keratometry readings: 42.50 D 42.50\text{ D} 42.50 D in both principal meridians ( K flat = 42.50 D K_{\text{flat}} = 42.50\text{ D} K flat ​ = 42.50 D ).

Manifest spectacle refraction: − 4.00 DS -4.00\text{ DS} − 4.00 DS ( d = 0 mm d = 0\text{ mm} d = 0 mm ).

Selected base curve: 43.25 D 43.25\text{ D} 43.25 D ( 0.75 D 0.75\text{ D} 0.75 D steeper than K flat K_{\text{flat}} K flat ​ ).

Calculate tear lens vergence: Because B C BC BC is 0.75 D 0.75\text{ D} 0.75 D steeper than flat K, the tear lens power is + 0.75 D +0.75\text{ D} + 0.75 D .

Apply SAM: Add − 0.75 D -0.75\text{ D} − 0.75 D to the spectacle refraction to neutralize the induced tear lens.

Contact lens power to order: − 4.00 DS − 0.75 D = − 4.75 DS -4.00\text{ DS} - 0.75\text{ D} = -4.75\text{ DS} − 4.00 DS − 0.75 D = − 4.75 DS .